Exhibit 11.1

Independent Registered Public Accounting Firm’s Consent

We consent to the inclusion in this Offering Statement of Glucose Biosensor Systems (Greater China) Holdings, Inc. (the “Company”) on Form 1-A of our report dated December 28, 2017, except for the effect of the stock split described in Note 1, as to which the date is June 7, 2018, with respect to our audit of the financial statements the Company as of June 30, 2017 and for the period from August 4, 2017 (inception) through June 30, 2017 and the report dated October 19, 2018 with respect to our audit of the financial statements the Company as of June 30, 2018 and for the year then ended. We also consent to the reference to our Firm under the heading “Experts” in such Offering Circular.